Skip to Content

MCR 313 (Lamivudine 150 mg)

Pill with imprint MCR 313 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Appco Pharma LLC.

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MCR 313

Lamivudine 150 mg MCR 313

Lamivudine

Imprint
MCR 313
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Appco Pharma LLC
National Drug Code (NDC)
55801-0313
Inactive Ingredients
hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.